Midday Report: Harmony (HRMY) Trades Higher May 13

Equities Staff  |

Harmony Biosciences Holdings Inc (NASDAQ: HRMY) shares are up 7.43%, or $2.61 per share, as on 11:57:06 est today. Since opening the day at $35.28, 134,977 shares of Harmony exchanged hands and the stock has traded between $37.84 and $35.28.  

Already this year the company is down 17.59%.

Harmony expects its next earnings on 2022-08-09.

For technical charts, analysis, and more on Harmony visit the company profile.

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc. operates as a pharmaceutical company. The Company focuses on the research, drug development, and treatment for neurologic disorder of sleep-wake state instability. Harmony Biosciences Holdings serves patients in the United States.

To get more information on Harmony Biosciences Holdings Inc and to follow the company's latest updates, you can visit the company's profile page here: Harmony Biosciences Holdings Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

Will New AT&T, Dish Co-opetition Deal Work: Jeff Kagan
Cisco Down 12% in Premarket Trading Thursday After Top Line Miss and Lower Forecast
Under Armour CEO Patrik Frisk To Step Down in Surprise Announcement
Target Hits 52-Week Low After Missing Badly on First Quarter Earnings
DLocal Posts Record Q1, Fifth Consecutive 100%+ Revenue Growth Quarter
Another Crypto Winter Wipes Out Billions in Market Value
Inflation + Recession = Recipe for Volatility

Market Movers

Sponsored Financial Content